-
University Spin-Off Developing Chemical ID Devices
A start-up company is licensing research from labs at Harvard University to make portable devices that quickly identify the chemistry of liquids.
-
FDA Funding Brain Tumor Treatment Trial
The biotechnology company DNAtrix is receiving a grant from U.S. Food and Drug Administration to support a clinical trial of its virus-delivered immunotherapy to treat an aggressive form of brain cancer.
-
Virtual Reality Added to Microscope in Brain Surgery
Neurosurgeons at Mount Sinai Medical Center in New York used virtual reality technology for the first time in a delicate procedure on a patient’s brain.
-
GMOs, 3D-Printed Chocolate, And The Rapid Development Of Food Technology
New, emerging technology is assisting us to analyze, track and organize the way we produce and consume food.
-
Electronic Tattoo Measures Blood Alcohol Level
A flexible electronic device worn on the skin like a tattoo can assess blood alcohol level and transmit the results to a nearby mobile phone.
-
Amgen, Advaxis Partner on Personal Cancer Immunotherapy
Biological drug maker Amgen is licensing precision immunotherapy technology from Advaxis Inc. to develop treatments for cancer.
-
Commercial Data Yield Genetic Links to Depression
An analysis of data from commercial genetic tests identified 15 regions in the genome and 17 specific variations associated with depression among people of European descent.
-
Trial to Assess Anti-Gravity Treadmill for Stress Test
Researchers at University of Cincinnati Medical Center plan to evaluate an anti-gravity treadmill for cardiac stress tests that check for heart disease.
-
GSK, Alphabet Form Bioelectronic Device Venture
Drug maker GlaxoSmithKline, or GSK, and Verily Life Sciences, a division of Alphabet, the parent company of Google, are forming a joint venture to develop miniaturized therapeutic electronic devices.
-
Portable On-Demand Biologic Production System Designed
A device that produces small batches of biological drugs, down to a single dose, was shown to generate two different biopharmaceuticals under lab conditions.